Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis

Unresectable glioblastomas with severe neurological impairment at diagnosis have a poor prognosis. The conventional approach using a temozolomide-based chemoradiotherapy has limited efficiency on patients in the RTOG RPA V–VI classes. The activity of the antiangiogenic monoclonal antibody bevacizuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bihan, Celina, Foscolo, Sylvain, Boone, Mathieu, Blonski, Marie, Coutte, Alexandre, Darlix, Amélie, Beauchesne, Patrick, Lefranc, Michel, Lorgis, Veronique, Taillandier, Luc, Chauffert, Bruno
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2012
Assuntos:
September, 2012
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3492967/
https://ncbi.nlm.nih.gov/pubmed/23139667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados